Second generation drug-eluting stents: A focus on safety and efficacy of current devices.

Second generation drug-eluting stents: A focus on safety and efficacy of current devices. Expert Rev Cardiovasc Ther. 2021 Jan 08;: Authors: Spione F, Brugaletta S Abstract INTRODUCTION: Percutaneous coronary intervention (PCI) represents the most frequent procedure performed in medicine. Second generation drug eluting stents (DES) have been developed to reduce the rates of late and very late complications of first generation DES. AREAS COVERED: To improve long-term efficacy and safety of patients undergoing PCI, second generation DES have been developed with novel stent platforms, biocompatible durable and biodegradable polymers and newer antiproliferative agents. In this review we provide an overview of second generation DES and their clinical trials, discussing safety and effectiveness of these devices, and outlining clinical indication for use. EXPERT COMMENTARY: Numerous clinical trials have demonstrated the safety and efficacy of second generation DES over the last decade. These devices represent the gold standard treatment in stable and acute coronary syndromes. PMID: 33417509 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research